跳到正文
原文
Medical Xpress·· 2026-10-05精选AI 评分70

人脑组织研究显示阻断 P2X7 受体可抑制与阿尔茨海默病相关的神经炎症

Brain tissue removed during surgery reveals potential way to curb inflammation linked to Alzheimer's

AI 导读

英国伯明翰大学 Nicholas Barnes 团队在 Brain 发表研究,利用神经外科手术获取的人脑组织切片和活细胞培养,发现用特异性拮抗剂阻断 P2X7 受体可显著降低人脑组织中的炎症反应。研究还建立了由外周血单核细胞转化的小胶质细胞样细胞模型,用于观察小胶质细胞在损伤死亡时释放的炎症信号。研究团队表示,下一步将针对神经退行性疾病和创伤性脑损伤患者开展临床试验。

推荐理由

研究以离体人脑组织和细胞模型观察阻断 P2X7 受体对炎症反应的影响,为后续临床转化提供可参考的路径。

正文
brain cells
Credit: CC0 Public Domain

Inflammatory conditions in the brain, including traumatic brain injury and degenerative diseases like Alzheimer's, could be targeted with an existing drug thanks to new research that shows it can work in brain cells.

In a study published in Brain, a team led by professor Nicholas Barnes at the University of Birmingham has identified a critical receptor that, when blocked, inhibits neuroinflammation. This first-of-its-kind work with human brain tissue demonstrates how interrupting this pathway could open the door to treating a wide spectrum of chronic neurological conditions. These include not only traumatic brain injury (TBI) but also neurodegenerative diseases such as Alzheimer's and Parkinson's disease, and even psychiatric disorders such as depression and psychosis. These latter conditions are increasingly understood to have a neuroinflammatory component.

Using live cultures of human brain cells and slices of brain tissue obtained during neurosurgery, the researchers investigated the role of a receptor known as the P2X7 receptor, which is responsible for triggering inflammatory signaling.

Their findings reveal that these P2X7 receptors drive the release of key proteins called cytokines involved in controlling inflammation. By blocking this receptor with a specific antagonist, the team was able to significantly reduce the inflammatory response in human brain tissue.

Barnes, from the College of Medicine and Health at the University of Birmingham and the paper's corresponding author, said, "This exciting discovery marks a major step toward repurposing existing therapeutics to combat neuroinflammation at its source. The identification of this receptor could have far-reaching implications for some of the most debilitating and widespread brain disorders such as Alzheimer's disease, Parkinson's and multiple sclerosis, or inflammation-linked psychiatric conditions like schizophrenia and depression."

Brain's resident immune sentinels

To study how brain cells respond to and manage inflammation, the team developed a way of turning a type of white blood cell into microglia, replicating a normal cellular transformation recently identified as occurring in the brain as a natural part of human aging. These microglia are the central coordinators of the immune system in the brain.

The researchers converted readily accessible human peripheral monocytes taken from blood samples into microglia-like cells that were used to see how microglia are likely to respond to inflammation signals. Using the P2X7 receptor antagonist, the team was then able to interrupt the triggers that these microglia give off as they are damaged and die.

Barnes said, "Studying human microglia has long been a major challenge: once removed from their native brain environment, they rapidly lose their defining characteristics, likely due to the absence of critical regulatory signals. Our approach involved the use of monocyte-derived microglia, which provide a powerful, scalable and virtually unlimited platform for studying human microglial biology with unprecedented precision.

"The response identified in the human monocyte-derived microglia provided the impetus to translate these findings to human brain tissue obtained following neurosurgical procedures. This successful translation means the next stage for this research is the development of clinical trials in patients with neurodegenerative conditions and patients with TBI, for whom there are no effective pharmacological treatments to reduce neuroinflammation and the resulting damage."

Publication details

Jamie Cowley et al, P2X7R-mediated IL-1β release by human brain tissue: the impact of CNS-penetrant potential therapeutics, Brain (2026). DOI: 10.1093/brain/awag068

Journal information: Brain

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Brain tissue removed during surgery reveals potential way to curb inflammation linked to Alzheimer's (2026, October 4) retrieved 4 October 2026 from https://medicalxpress.com/news/2026-10-brain-tissue-surgery-reveals-potential.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com